Thus, we performed shRNA-induced knockdown of one or both of the catalytic subunits of AMPK in pancreatic cancer cell lines to determine whether the anti-proliferative effects of metformin would be affected. This evidence concerns the gene PRKAA1 and pancreatic neoplasm.